These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9091524)

  • 1. Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval.
    Singh JP; Johnston J; Sleight P; Bird R; Ryder K; Hart G
    J Am Coll Cardiol; 1997 Mar; 29(4):778-84. PubMed ID: 9091524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy.
    Passino C; Franzoni F; Gabutti A; Poletti R; Galetta F; Emdin M
    Int J Cardiol; 2004 Oct; 97(1):57-62. PubMed ID: 15336807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns.
    Salles GF; Cardoso CR; Deccache W
    J Hum Hypertens; 2003 Aug; 17(8):561-7. PubMed ID: 12874614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension.
    Salles G; Leocádio S; Bloch K; Nogueira AR; Muxfeldt E
    Hypertension; 2005 Nov; 46(5):1207-12. PubMed ID: 16203872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.
    Piccirillo G; Germanò G; Quaglione R; Nocco M; Lintas F; Lionetti M; Moisè A; Ragazzo M; Marigliano V; Cacciafesta M
    Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension.
    Karpanou EA; Vyssoulis GP; Psichogios A; Malakou C; Kyrozi EA; Cokkinos DV; Toutouzas PK
    Am Heart J; 1998 Nov; 136(5):765-8. PubMed ID: 9812069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Fallahi P; Tocchini L; Graci F; Carpi A; Antonelli A; Santoro G
    Biomed Pharmacother; 2010 Oct; 64(8):516-20. PubMed ID: 20044234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left ventricular hypertrophy increases the frequency of ventricular arrhythmia in hypertensive patients].
    Ozdemir A; Telli HH; Temizhan A; Altunkeser BB; Ozdemir K; Alpaslan M; Karabağ T
    Anadolu Kardiyol Derg; 2002 Dec; 2(4):293-9. PubMed ID: 12460824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT dispersion in patients with different etiologies of left ventricular hypertrophy: the significance of QT dispersion in endurance athletes.
    Zoghi M; Gürgün C; Yavuzgil O; Akilli A; Türkoglu C; Kültürsay H; Akin M
    Int J Cardiol; 2002 Aug; 84(2-3):153-9. PubMed ID: 12127367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.
    Perkiömäki JS; Ikäheimo MJ; Pikkujämsä SM; Rantala A; Lilja M; Kesäniemi YA; Huikuri HV
    Hypertension; 1996 Jul; 28(1):16-21. PubMed ID: 8675257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT dispersion in hypertensive Nigerians with and without left ventricular hypertrophy.
    Ale OK; Ajuluchukwu JN; Oke DA; Mbakwem AC
    West Afr J Med; 2013; 32(1):57-61. PubMed ID: 23613296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exercise on QT dispersion in hypertensive patients with left ventricular hypertrophy without coronary artery disease.
    Yoshimura M; Matsumoto K; Watanabe M; Yamashita N; Sanuki E; Sumida Y
    Jpn Circ J; 1999 Nov; 63(11):881-4. PubMed ID: 10598895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
    Malmqvist K; Kahan T; Edner M; Bergfeldt L
    Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy increases transepicardial dispersion of repolarisation in hypertensive patients: a differential effect on QTpeak and QTend dispersion.
    Wolk R; Mazurek T; Lusawa T; Wasek W; Rezler J
    Eur J Clin Invest; 2001 Jul; 31(7):563-9. PubMed ID: 11454009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.